Invokamet | Heygood, Orr & Pearson

Heygood, Orr & Pearson

Real Trial Lawyers for Real Problems

Tag Archives: Invokamet

FDA warns Invokana can increase amputation risk for diabetes patients

August 21st, 2017

Diabetes patients taking Invokana and other medications containing the drug canagliflozin may face an increased risk of lower limb amputation, …

Tags: canagliflozin, foot amputation, Invokamet, Invokana, leg amputation, type 2 diabetes
Posted in HO&P Legal Blog, Invokana |

FDA warning of coma, death risk from high blood acid level complications from popular diabetes drugs

June 8th, 2015

The Food and Drug Administration has issued a warning about a risk of life-threatening complications in patients taking a new …

Tags: diabetes, Farxiga, Glyxambi, Invokamet, Invokana, Janumet, Januvia, Jardiance, ketoacidosis, SGLT2 inhibitors, Xigduo XR
Posted in HO&P Legal Blog, Januvia and Janumet, Pharmaceutical Liability |